Market cap
$18,493 Mln
Recently Viewed
Clear All$274.72
$-3.28
(-1.18%)
As on 21-Apr-2026 16:00EDT
Market cap
$18,493 Mln
Revenue (TTM)
$3,074 Mln
P/E Ratio
37.7
P/B Ratio
5.8
Div. Yield
0.3 %
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
$494 Mln
ROE
0.2 %
ROCE
15 %
Industry P/E
--
EV/EBITDA
23.3
Debt to Equity
0.1
Book Value
$43.7
EPS
$6.8
Face value
--
Shares outstanding
72,081,610
CFO
$4,090.80 Mln
EBITDA
$4,876.40 Mln
Net Profit
$3,152.90 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
West Pharmaceutical Services (WST)
| -0.2 | 15.9 | 5.7 | 36.1 | -8.7 | -3.0 | 14.3 |
|
BSE Sensex*
| -7.3 | 5.3 | -4.1 | -1.1 | 9.6 | 10.5 | 11.7 |
|
S&P 100
| 0.2 | 8.9 | 2.3 | 36.1 | 22.5 | 12.9 | 14.0 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
West Pharmaceutical Services (WST)
| -16.0 | -6.9 | 49.6 | -49.8 | 65.9 | 89.0 | 54.1 |
|
S&P 100
| 18.7 | 29.0 | 30.8 | -22.1 | 27.6 | 19.3 | 29.5 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
West Pharmaceutical Services (WST)
|
274.7 | 18,492.5 | 3,073.7 | 493.7 | 19.7 | 16.9 | 37.7 | 5.8 |
| 92.7 | 168,225.1 | 45,134.0 | 6,276.0 | 15.4 | 24.6 | 26.7 | 3.2 | |
| 156.7 | 56,420.2 | 21,923.0 | 1,757.0 | 12.0 | 6.9 | 25.4 | 1.7 | |
| 59.5 | 94,253.2 | 20,074.0 | 2,886.0 | 14.7 | 12.5 | 32.7 | 4.0 | |
| 194.5 | 137,138.0 | 24,568.0 | 3,614.0 | 18.3 | 7.1 | 38.4 | 2.7 | |
| 79.7 | 45,372.1 | 6,067.6 | 1,073.5 | 20.4 | 10.6 | 43.2 | 4.3 | |
| 569.0 | 46,918.5 | 4,303.7 | 1,059.5 | 31.7 | 66.2 | 45 | 29.2 | |
| 451.3 | 166,649.2 | 10,064.7 | 2,856.0 | 29.3 | 16.7 | 59.5 | 9.1 | |
| 327.3 | 129,885.3 | 25,116.0 | 3,246.0 | 17.9 | 15.1 | 40.3 | 5.7 | |
| 524.6 | 191,756.6 | 44,556.0 | 6,737.0 | 19.5 | 13.1 | 29.1 | 3.7 |
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments,... Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging products. This segment also provides drug containment solutions in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment primarily serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania. Read more
Non-Independent Chair of the Board, President & CEO
Mr. Eric M. Green
Senior VP & Chief Commercial Officer
Ms. Cindy Reiss-Clark
Headquarters
Exton, PA
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of West Pharmaceutical Services Inc (WST) is $274.72 (NYSE) as of 21-Apr-2026 16:00 EDT. West Pharmaceutical Services Inc (WST) has given a return of -8.74% in the last 3 years.
The P/E ratio of West Pharmaceutical Services Inc (WST) is 37.73 times as on 10-Apr-2026.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
40.52
|
6.30
|
|
2024
|
49.00
|
9.00
|
|
2023
|
44.50
|
9.17
|
|
2022
|
30.37
|
6.63
|
|
2021
|
54.14
|
15.34
|
The 52-week high and low of West Pharmaceutical Services Inc (WST) are Rs 322.00 and Rs 199.89 as of 22-Apr-2026.
West Pharmaceutical Services Inc (WST) has a market capitalisation of $ 18,493 Mln as on 10-Apr-2026. As per SEBI classification, it is a Large Cap company.
Before investing in West Pharmaceutical Services Inc (WST), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.